Science Ventures

Science Ventures Denmark A/S, established in 2005, is a private subsidiary of the University of Southern Denmark, located in Odense. The company focuses on developing high-tech startups in close collaboration with researchers, industry partners, and investors both locally and internationally. By leveraging innovations from the university and its hospital, Science Ventures aims to create and commercialize advanced technologies across various sectors. The startups that emerge from this initiative have generated over 1,000 high-tech jobs and have successfully marketed their products globally, covering areas such as LED technology, molecular advancements, and robotics.

Jens Kristian Damsgaard

CEO

8 past transactions

FUZE Technology

Series A in 2024
Portable phone charging made easy. Pick-up & drop-off portable chargers anywhere in your city via our chargeFUZE APP.

ABL Space Systems

Venture Round in 2020
ABL Space Systems specializes in designing and manufacturing rockets for the launch of small satellites. Incorporated in 2017 and based in El Segundo, California, the company focuses on developing low-cost and reliable launch vehicles, with its primary product being the RS1 rocket. This vehicle is capable of carrying payloads of up to 1,350 kilograms to Low Earth Orbit (LEO) and supports various configurations, including multi-manifest and dedicated deployments. In addition to the RS1, ABL also creates the GS0 ground system, which facilitates rapid deployment and integration of launch operations at multiple sites. The company operates from a 30,000 square foot facility dedicated to research, development, and production, and is privately owned, supported by a group of private equity investors.

InnoCell

Venture Round in 2018
InnoCell specializes in the development of a patented supercapacitor technology that focuses on rapidly storing energy in a sustainable and economical way. The company's innovative approach combines both aqueous and organic electrolytes, resulting in high conductivity and enhanced voltage handling capabilities. This technology aims to improve energy efficiency while eliminating harmful components commonly associated with traditional supercapacitors, providing clients with a cleaner and more effective energy storage solution.

Smooth Robotics

Seed Round in 2017
Smooth Robotics specializes in intuitive robotic welding software, aimed at automating welding processes for clients. Their flagship product, SmoothTool, enhances the capabilities of Universal Robots, converting its robotic arm into a powerful and user-friendly welding tool. The platform allows operators to teach the robot the welding path and techniques using a joystick mounted on the robot, simplifying the programming process. This innovative approach enables users to achieve automated welding with ease, ensuring consistent and high-quality results without the complexities typically associated with traditional programming methods.

NanOrig

Venture Round in 2016
NanOrig develops safety labels that will protect products against piracy. On the surface of the marks are small pieces of crystal with organic nanofibres. These can be compared to human fingerprints.

Enabled Robotics

Seed Round in 2016
Enabled Robotics specialize in systems with robot arms mounted on mobile platforms thereby combining mobility with the capability of solving complex tasks. Enabled Robotics ApS was founded in 2016 by Science Ventures Denmark and Lars-Peter Ellekilde as a spin-out of the University of Southern Denmark. In 2017 Per Ibsen from PI Consult & Invest invested in Enabled Robotics ApS enabling us to hire the first developer.

Caldan Therapeutics

Series A in 2015
Caldan Therapeutics Ltd is a spinout company from the University of Glasgow (UofG) and the University of Southern Denmark (SDU), developing novel therapeutics targeting modulators of free fatty acid receptors, for metabolic disease including Type 2 Diabetes (T2D) and other indications. The spinout opportunity has arisen from a long term collaboration between Professor Graeme Milligan (UofG) and Professor Trond Ulven (SDU). Free fatty acid receptors have recently emerged as exciting targets for T2D, due to their involvement in multiple aspects of T2D pathophysiology. There may also be potential to explore other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases.

Othonia Curing Technology

Venture Round in 2013
Othonia Curing Technology develops UV/LED fixtures for curing in the paint/varnish industry and flexography industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.